Status:
UNKNOWN
Randomized, Controlled Trial of Endoscopic Ultrasound-Guided Bilateral Celiac Plexus Neurolysis vs Celiac Ganglia Neurolysis to Control Pain in Inoperable Pancreatic Cancer Patients With Inadequate Pain Control by Pain Killer
Lead Sponsor:
Samsung Medical Center
Conditions:
Pancreatic Neoplasms
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Pancreatic cancer related pain can be difficult to control, even with high doses of narcotics, whose adverse effects may further impair quality of life. So EUS-CPN(endoscopic ultrasound guided celiac ...
Eligibility Criteria
Inclusion
- At least 19 years old age (above 70 years old age, need the consent of the legal representative)
- Inoperable pancreatic cancer patients
- Pancreatic cancer patients with inadequate pain control by pain killer (VAS score 4 points or more)
- Patient who agree to participate in this study
Exclusion
- Abnormal clotting (international normalized ratio ≥1.5)
- Reduced platelet count (≤50000/μL)
- Use of anticoagulation agents
- Presence of gastric and/or esophageal varices
- Anatomical deformity due to past surgery
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
166 Patients enrolled
Trial Details
Trial ID
NCT02220062
Start Date
August 1 2014
Last Update
August 19 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.